Core Insights - Aflac Re Bermuda Ltd. has entered into a reinsurance agreement with Japan Post Insurance Company to reinsure a block of whole life annuities through coinsurance, effective March 31, 2026 [1][2] - This transaction is significant as it marks Aflac Re's first reinsurance deal with an external party, enhancing its strategic partnership with Japan Post Insurance [2] Company Overview - Aflac Incorporated is a leading life and health insurer with a strong presence in both Japan and the U.S., recognized as the No. 1 provider of supplemental health insurance in the U.S. and the leading provider of cancer and medical insurance in Japan [2] - The company has been acknowledged for its ethical practices, being listed among the World's Most Ethical Companies for 20 consecutive years and Fortune's World's Most Admired Companies for 25 years [2] Strategic Goals - Aflac aims to create shared value for policyholders and shareholders through this partnership with Japan Post Insurance, while also looking to support other Japanese life insurers in risk reduction and capital management [2]

Core Insights - Aflac Incorporated will have President Virgil R. Miller participate in a fireside chat at the UBS Financial Services Conference on February 11, 2026, at 9:40 a.m. ET, which will be webcast live [1] Company Overview - Aflac Incorporated is a Fortune 500 company that has provided financial protection for over 70 years to millions of policyholders through its subsidiaries in the U.S. and Japan [2] - In the U.S., Aflac is the leading provider of supplemental health insurance products, while in Japan, Aflac Life Insurance Japan is the top provider of cancer and medical insurance based on policies in force [2] - The company has been recognized as one of the World's Most Ethical Companies for 19 consecutive years and has been included in Fortune's World's Most Admired Companies for 24 years [2] - Aflac became a signatory of the Principles for Responsible Investment in 2021 and has been part of the Dow Jones Sustainability North America Index for 11 years [2] Event Information - A replay of the presentation will be available within 24 hours after the live event [2]

Core Insights - Aflac Incorporated is a significant player in the insurance industry, particularly known for its supplemental health insurance products in the U.S. and cancer and medical insurance offerings in Japan [1] Group 1: Company Performance - Barclays has maintained an "Underweight" rating for Aflac, while increasing the price target to $102 from $100, despite the stock price being $112.93 at the time [2][5] - Aflac's stock has shown volatility, trading between $112.55 and $113.89, with a market capitalization of approximately $60.4 billion [4][5] - Over the past year, Aflac's stock reached a high of $115.44 and a low of $96.95, indicating fluctuations in performance [4] Group 2: Commitment to Policyholders - Aflac has introduced a grace period for premium payments for federal employees affected by the government shutdown, demonstrating its commitment to supporting policyholders during challenging times [3][5]